Reductionist Fallacies in the Theory and Treatment of Mental Disorders

References

• J.T.A. [John Thomas Arlidge] (1856) An examination of the practice of bloodletting in mental disorders, by Pliny Earle, MD. New York, 1854. The Asylum Journal of Mental Science, 2, 167.
   Google Scholar
• An extract of a letter written by J. Denis, Doctor of Physick and Professor of Philosophy and the Mathematics at Paris, touching a late cure of an inveterate phrenzy by the transfusion of blood (1668) Philosophical Transactions of the Royal Society of London, No. 32, pp. 617–23.
   Google Scholar
• An account of the experiment of transfusion, practiced upon a man in London (1667) Philosophical Transactions of the Royal Society of London, No. 30, pp. 557–59.
   Google Scholar
• Miss Pascal & Davesne, J. (1925) La thérapeutique sanguine dans les psychoses. La Presse Médicale, 23, 1126.
   Google Scholar
• Goldbladt, H., & Krapiwkin, A. (1932) Therapeutische Versuche mit Bluttransfusion bei Schizophrenie. Psychiatrisch-Neurologische Wochenschrift, 34, 638.
   Google Scholar
• Reiter, P.J. (1938). Untersuchungen zur Beleuchtung der Intoxikationstheorie bei der Dementia praecox mit besonderer Berücksichtigung der Versuche mit Total-transfusionen. Zentralblatt für die gesamte Neurologie und Psychiatrie, 160, 598.
   Google Scholar
• Pfeffer, A.Z., & Pescor, J.J. (1944) Multiple transfusions for schizophrenia. Archives of Neurology and Psychiatry, 52, 131.
   Google Scholar
• Freedman, A.M., & Ginsberg, V. (1958) Exchange transfusions in schizophrenic patients. Journal of Nervous and Mental Disease, 126, 294.
   PubMed Web of Science ®Google Scholar
• Nicklin, G., Sacks, W., Wehrheim, H., Simpson, G., Saunders, J., & Kline, N. (1959) Cross transfusion in schizophrenia. American Journal of Psychiatry, 116, 334.
   PubMed Web of Science ®Google Scholar
• Kielholz, P. (1949) Über Ergebnisse der Behandlung akuter Katatonien mit der Durchblutungsmethode. Schweizerische Archiv für Neurologie und Psychiatrie, 63, 230.
   Google Scholar
• Feer, H., Thoelen, H., Massini, M.-A., & Staub, H. (1960) Hemodialysis in schizophrenia. Comparative Psychiatry, 1, 338.
   PubMed Web of Science ®Google Scholar
• Belov, V.P., & Kuchinskii, I.N. (1963) [Experimental use of an artificial-kidney machine in the treatment of schizophrenic patients]. Zhurnal Nevropatologii i Psikhiatrii imeni S.S. Korsakova, 63, 1856.
   PubMed Web of Science ®Google Scholar
• Wagemaker, H., & Cade, R. (1977) The use of hemodialysis in chronic schizophrenia. American Journal of Psychiatry, 134, 684.
   PubMed Web of Science ®Google Scholar
• Wagemaker, H., Rogers, J.L., & Cade, R. (1983) The experimental use of hemodialysis in a double-blind study of 24 chronic schizophrenics. Psychopharmacology Bulletin, 19, 33.
   Web of Science ®Google Scholar
• Tovar, E. (1987) Patients applaud controversial aid for schizophrenia. The Florida Times UnionlJacksonville Journal, 1 November. Pp. Al, A8.
   Google Scholar
• Kolff, W.J. (1978) Dialysis of schizophrenics. Weird and novel application of dialysis, hemofiltration, hemoperfusion and peritoneal dialysis: Witchcraft? Artificial Organs, 2, 277.
   PubMed Web of Science ®Google Scholar
• Palmour, R.M., Ervin, F.R., Wagemaker, H., & Cade, R. (1979) Characterization of a peptide from the serum of psychotic patients. In E. Usdin, W.E. Bunney, & N.S. Kline (Eds.), Endorphins in mental health research. New York: Macmillan. Pp. 581–93.
   Google Scholar
• Levy, N.B. (1979) Hemodialysis for schizophrenia. A voice of skepticism. Dialysis and Transplantation, 8, 86.
   Web of Science ®Google Scholar
• Stephen, R.L., Velick, S.F., Kablitz, C., & Grosser, B.I. (1979) Dialysis/hemofiltration in schizophrenia: A journey by night and cloud. Artificial Organs, 3, 31.
   PubMed Web of Science ®Google Scholar
• Phillipp, M. (1979) Hämodialyse und die Idee der Blutentgiftung in der Schizophreniebehandlung. Fortschritte der Neurologie und Psychiatrie, 47, 36.
   Google Scholar
• Schulz, S.C., van Kammen, D.P., Balow, J.E., Flye, M.W., & Bunney, W.E. (1981) Dialysis in schizophrenia: A double-blind evaluation. Science, 211, 1066.
   PubMed Web of Science ®Google Scholar
• Carpenter, W.T., Sadler, J.H., Light, P.D., Hanlon, T.E., Kurland, A.A., Penna, M.W., Reed, W.P., Wilkinson, E.H., & Bartko, J.J. (1983) The therapeutic efficacy of hemodialysis in schizophrenia. The New England Journal of Medicine, 308, 669.
   PubMed Web of Science ®Google Scholar
• Vanherweghem, J.-L., Linkowski, P., & Mendlewicz, J. (1983) Hemodialysis in schizophrenia. A double-blind study. Archives of General Psychiatry, 40, 211.
   PubMed Web of Science ®Google Scholar
• Bagadia, V.N., Shah, L.P., Pradhan, P.V., Gada, M.T., Ayyar, K.S., Acharya, V.N., & Sheth, S.M. (1984) Hemodialysis and peritoneal dialysis in chronic refractory schizophrenia. Psychopharmacology Bulletin, 20, 323.
   PubMed Web of Science ®Google Scholar
• Robertson, F. (1901) The role of toxic action in the pathogenesis of insanity. The Medical Press, ii, 160.
   Google Scholar
• Wagner v. Jauregg, J. (1902) Ueber Psychosen durch Autointoxication vom Darme aus. Jahrbücher für Psychiatrie und Neurologie, 22, 177.
   Google Scholar
• Keup, W. (1954) Die “Biochemie der Schizophrenie.” Eine kritische Stellungnahme. Monatschrift für Psychiatrie und Neurologie, 128, 56.
   PubMedGoogle Scholar
• Kety, S.S. (1959) Biochemical theories of schizophrenia. Science, 129, 1590.
   PubMed Web of Science ®Google Scholar
• Heath, R.G., Martens, S., Leach, B.E., Cohen, M., & Angel, C. (1958) Effect on behavior in humans with the administration of taraxein. American Journal of Psychiatry, 114, 14.
   Web of Science ®Google Scholar
• Heath, R.G., Martens, S., Leach, B.E., Cohen, M., & Feigley, C.A. (1958) Behavioral changes in nonpsychotic volunteers following the administration of taraxein, the substance obtained from serum of schizophrenic patients. American Journal of Psychiatry, 114, 911.
   Google Scholar
• Smith, K. (1958) In discussion of the paper by Heath et al. [30]. American Journal of Psychiatry, 114, 920.
   Google Scholar
• Bourdillon, R.E., Clarke, C.A., Ridges, A.P., Sheppard, P.M., Harper, P., & Leslie, S.A. (1965) “Pink spot” in the urine of schizophrenics. Nature, 208, 453.
   PubMed Web of Science ®Google Scholar
• Tellegen Dr. (1891) The use of opium in melancholic states. The Journal of Mental Science, 37, 632.
   Google Scholar
• Bloom, F., Segal, D., Ling, N., & Guillemin, R. (1976) Endorphins: profound behavioral effects in rats suggest new etiological factors in mental illness. Science, 194, 630.
   PubMed Web of Science ®Google Scholar
• Jacquet, Y.F., & Marks, N. (1976) The C-fragment of β-lipotropin: An endogenous neuroleptic or antipsychotogen? Science, 194, 632.
   PubMed Web of Science ®Google Scholar
• Cohen, M.R., Pickar, D., Extein, I., Gold, M.S., & Sweeney, D.R. (1984) Plasma cortisol and ß-endorphin immunoreactivity in nonmajor and major depression. American Journal of Psychiatry, 141, 628.
   PubMed Web of Science ®Google Scholar
• Coid, J., Allolio, B., & Rees, L. H. (1983) Raised plasma metenkephalin in patients who habitually mutilate themselves. Lancet, 2, 545.
   PubMed Web of Science ®Google Scholar
• Schulz, S.C., van Kammen, D.P., Pickar, D., Cohen, M.R., & Naber, D. (1982) Response of plasma beta-endorphin immunoreactivity to d-amphetamine and placebo in schizophrenic patients. Psychiatry Research, 7, 171.
   PubMed Web of Science ®Google Scholar
• Anon. (1982) Psychodrug pioneer to experiment no more. Medical World News, 21 June. P. 14.
   PubMedGoogle Scholar
• Gunne, L.-M., Lindström, L., & Terenius, L. (1977) Naloxone-induced reversal of schizophrenic hallucinations. Journal of Neural Transmission, 40, 13.
   PubMed Web of Science ®Google Scholar
• Gunne, L.-M., Lindström, L., & Widerlöv, E. (1979) Possible role of endorphins in schizophrenia and other psychiatric disorders. In E. Usdin, W.R. Bunney, & N.S. Kline (Eds.), Endorphins in mental health research. New York: Macmillan. Pp. 547–52.
   Google Scholar
• Orr, M., & Oppenheimer, C. (1978) Effects of naloxone on auditory hallucinations. British Medical Journal, 1, 48.
   Google Scholar
• Van Praag, H.M., & Verhoeven, W.M.A. (1982) Neurotransmitters and schizophrenia. Part B: Endorphins and schizophrenia. In P.J.V. Beumont & G.D. Burrows (Eds.), Handbook of psychiatry and endocrinology. Amsterdam: Elsevier Biomedical Press. Pp. 201–214.
   Google Scholar
• Pickar, D., Vartanian, F., Bunney, W.E., Maier, H.P., Gastpar, M.T., et al. (1982) Short-term naloxone administration in schizophrenic and manic patients. A World Health Organization collaborative study. Archives of General Psychiatry, 39, 313.
   PubMed Web of Science ®Google Scholar
• Kane, J., & Di Scipio, W.J. (1979) Acupuncture treatment of schizophrenia: Report of three cases. American Journal of Psychiatry, 136, 297.
   PubMed Web of Science ®Google Scholar
• Bullock, M.L., Culliton, P.D., & Olander, R.T. (1989) Controlled trial of acupuncture for severe recidivist alcoholism. Lancet, 1, 1435.
   PubMed Web of Science ®Google Scholar
• Hoffer, A., Osmond, H., & Smythies, J. (1954) Schizophrenia: A new approach, II. Result of a year’s research. Journal of Mental Science, 100, 29.
   PubMed Web of Science ®Google Scholar
• McMichael, A.J. (1981) Orthomolecular medicine and megavitamin therapy. The Medical Journal of Australia, i, 6.
   Google Scholar
• American Psychiatric Association Task Force on Vitamin Therapy in Psychiatry (1973) Megavitamin and orthomolecular therapy in psychiatry. Washington, DC: American Psychiatric Association.
   Google Scholar
• Hoffer, A., & Osmond H. (1976) Megavitamin therapy. In reply to the American Psychiatric Association Task Force report on Megavitamins and orthomolecular psychiatry. Regina, Saskatchewan: Canadian Schizophrenia Foundation.
   Google Scholar
• Pauling, L. (1968) Orthomolecular psychiatry. Science, 160, 265.
   PubMed Web of Science ®Google Scholar
• Pauling, L. (1974) On the orthomolecular environment of the mind: Orthomolecular theory. American Journal of Psychiatry, 131, 1251.
   PubMed Web of Science ®Google Scholar
• Pfeiffer, C.C. (1987) Mental illness and schizophrenia. The nutrition connexion. Wellingborough: Thorson Publishing Group.
   Google Scholar
• Nowlan, D. (1986) Food allergy “may have affected Hitler.” The Irish Times, 28 September.
   Google Scholar
• Gray, G.E. (1986) Diet, crime and delinquency: A critique. Nutrition Reviews, 44, 89.
   PubMed Web of Science ®Google Scholar
• Anon. (1986) Crisps “nearly turned man into killer.” The Irish Times, 20 September.
   Google Scholar
• Anon. (1988) Junk food link to hooliganism. The Independent (London), 5 August
   Google Scholar
• Prentice, T. (1988) Mind-bending LSD found in wholemeal bread and cereals. The Times (London), 7 September.
   Google Scholar
• Ferry, G. (1983) Eat your way to mental health. New Scientist, 6 October. Pp. 46–47.
   Web of Science ®Google Scholar
• Anon. (1983) Gluten in schizophrenia (Editorial). Lancet, 1, 744.
   PubMedGoogle Scholar
• Storms, L.H., Clopton, J.M., & Wright, C. (1982) Effects of gluten on schizophrenics. Archives of General Psychiatry, 39, 323.
   PubMed Web of Science ®Google Scholar